Ordenar

Buscar

01/03/2026 Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes
Gonzalez-Manzanares, R, Anguita-Gámez, M, Muñiz, J, Barrios, V, Gimeno-Orna, JA, Pérez, A, Rodríguez-Padial, L, Anguita, M. Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes. JOURNAL OF WOMENS HEALTH. 2026; 35(3)DOI:10.1177/15409996251401741. PMID:41449991. IF:1.900(Q1/2D).
01/03/2026 Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
Paz-Ares, L, Veillon, R, Majem, M, Zhou, CC, Tang, KJ, Kim, SW, Richardson, G, Girard, N, Sanborn, RE, Mansfield, AS, Park, K, Schuchard, J, Diels, J, Sermon, J, Bhattacharya, A, Lorenzini, P, Wortman-Vayn, H, Knoblauch, RE, Agrawal, T, Baig, M, Ono, A, Sabari, JK. Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC. LUNG CANCER. 2026; 213DOI:10.1016/j.lungcan.2025.108788. PMID:41671629. IF:4.400(Q1/2D).
01/03/2026 Urinary glucose tetrasaccharide tracks disease activity in late-onset Pompe disease
Dominguez-González, C, Iannucci, D, Clark, J, Martin-Jiménez, P, Hold, S, Oliva, P, Bischinger, A, Gallardo, E, Diaz-Manera, J. Urinary glucose tetrasaccharide tracks disease activity in late-onset Pompe disease. NEUROMUSCULAR DISORDERS. 2026; 60DOI:10.1016/j.nmd.2026.106359. PMID:41638029. IF:2.800(Q2/5D).
01/03/2026 Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood
Pérez-González, R, Vázquez-Oliver, A, Rivas-Asensio, E, Campolongo, A, Pons-Pons, G, Martínez-Horta, S, Pagonabarraga, J, Pascual-Sedano, B, Kulisevsky, J. Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood. PARKINSONISM & RELATED DISORDERS. 2026; 144DOI:10.1016/j.parkreldis.2026.108208. PMID:41643584. IF:3.400(Q2/3D).
01/03/2026 Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration
Garcia-Castro, J, Vandevrede, L, Donohue, MC, Vaqué-Alcázar, L, Rubio-Guerra, S, Selma-González, J, Heuer, HW, Morcillo-Nieto, AO, Franquesa, M, Dols-Icardo, O, Bejanin, A, Belbin, O, Fortea, J, Alcolea, D, Carmona-Iragui, M, Abdelnour, C, Barroeta, I, Santos-Santos, M, Saudinós, MBS, Sala, I, Lleó, A, Gorno-Tempini, ML, Mandelli, ML, Raman, R, Wills, AM, Barragan, E, Litvan, I, Boeve, B, Dickerson, B, Grossman, M, Huey, ED, Irwin, DJ, Pantelyat, A, Tartaglia, C, Rojas, JC, Boxer, AL, Illán-Gala, I. Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration. JPAD-Journal of Prevention of Alzheimers Disease. 2026; 13(3)DOI:10.1016/j.tjpad.2026.100486. PMID:41581260. IF:7.800(Q1/1D).
01/03/2026 Atypical Anti-Glomerular Basement Membrane Disease
Fernández-Lorente, L, Shabaka, A, Mora-Gutiérrez, JM, Caravaca-Fontán, F, Maldonado-Martin, M, Cabello, V, Marco, H, Temprado, A, Rivera, C, Facal, L, Barros, X, Manrique, J, Santos, AP, Fernández-Juárez, G, González, CC. Atypical Anti-Glomerular Basement Membrane Disease. Kidney International Reports. 2026; 11(3)DOI:10.1016/j.ekir.2025.103732. PMID:41584267. IF:5.700(Q1/1D).
01/03/2026 SGLT2 inhibitors in acute heart failure: Intermediate eGFR stratum, potential biases, and applicability in the Emergency Department
Agra Montava, I, Motos Bescos, M, Moline Parejay, A. SGLT2 inhibitors in acute heart failure: Intermediate eGFR stratum, potential biases, and applicability in the Emergency Department. MEDICINA CLINICA. 2026; 166(3)DOI:10.1016/j.medcli.2025.107332. PMID:41604866. IF:2.100(Q2/3D).
01/03/2026 Dose Mapping Using Image Registration for Reirradiation: A Systematic Review
Thiongo, CM, Davey, A, Appelt, A, Day, M, Dupuis, P, Monti, S, Perez-Alija, J, Skopidou, T, Svensson, S, Osorio, EV. Dose Mapping Using Image Registration for Reirradiation: A Systematic Review. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2026; 124(3)DOI:10.1016/j.ijrobp.2025.09.053. PMID:41083027. IF:6.500(Q1/1D).